Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intellia Therapeutics, Inc. - Common Stock (NQ: NTLA )

12.12 +0.07 (+0.58%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,802,215
Open 11.83
Bid (Size) 12.06 (1)
Ask (Size) 12.12 (1)
Prev. Close 12.05
Today's Range 11.61 - 12.23
52wk Range 11.61 - 34.87
Shares Outstanding 88,140,978
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Peering Into Intellia Therapeutics's Recent Short Interest
Via Benzinga
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
Cathie Wood, CEO of ARK Invest, is doubling down on biologics, seeing unprecedented potential at the intersection of artificial intelligence, genetic sequencing, and gene editing technologies. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
-60.67%
-60.67%
1 Month
-17.72%
-17.72%
3 Month
-41.08%
-41.08%
6 Month
-47.74%
-47.74%
1 Year
-61.81%
-61.81%

More News

Read More
Down 33% in 1 Month, Should You Buy the Dip With Intellia Therapeutics Stock?
Via The Motley Fool
From GLD To TSLA: Unlocking Today’s Best Trading Opportunities
Via Talk Markets
Topics Stocks / Equities
Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
9 Analysts Have This To Say About Intellia Therapeutics
Via Benzinga
A Glimpse of Intellia Therapeutics's Earnings Potential
Via Benzinga
Looking Into Intellia Therapeutics's Recent Short Interest
Via Benzinga
3 Fast-Growing Stocks Analysts See Doubling in Price
Via MarketBeat
Intellia Therapeutics Just Notched Another Win. So Why Did Its Stock Fall 18% in 1 Day?
Via The Motley Fool
This Beaten-Down Stock Could Soar by 354%, According to Wall Street
Via The Motley Fool
12 High-Growth Stocks That Could Deliver Parabolic Returns
Via The Motley Fool
7 Analysts Have This To Say About Intellia Therapeutics
Via Benzinga
A Closer Look at Intellia Therapeutics's Options Market Dynamics
Via Benzinga
3 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Expert Outlook: Intellia Therapeutics Through The Eyes Of 7 Analysts
Via Benzinga
Monopar Therapeutics, Intellia Therapeutics, Capri Holdings, Western Digital, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Topics Stocks
Exposures US Equities
Why Intellia Therapeutics Stock Plummeted by 20% Today
Via The Motley Fool
Why Is Gene Therapy-Focused Intellia Therapeutics Stock Trading Lower On Thursday?
Via Benzinga
This Beaten-Down Growth Stock Could Skyrocket 234%, According to Wall Street
Via The Motley Fool
2 Cathie Wood Stocks That Could Soar 32% and 282%, According to Wall Street
Via The Motley Fool
Expert Ratings For Intellia Therapeutics
Via Benzinga
2 Innovative Cathie Wood Stocks to Buy If You Can Stomach the Risk
Via The Motley Fool
3 Gene Editing Stocks with Potential to Transform Medicine
Via InvestorPlace
NTLA Stock Earnings: Intellia Therapeutics Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.